Short Interest in Integer Holdings Co. (NYSE:ITGR) Increases By 19.8%

Integer Holdings Co. (NYSE:ITGR - Get Free Report) was the target of a significant growth in short interest during the month of March. As of March 15th, there was short interest totalling 2,660,000 shares, a growth of 19.8% from the February 28th total of 2,220,000 shares. Based on an average trading volume of 370,400 shares, the days-to-cover ratio is presently 7.2 days. Currently, 8.2% of the company's stock are sold short.

Integer Stock Performance

Shares of NYSE ITGR traded down $2.20 during trading hours on Friday, reaching $113.87. The stock had a trading volume of 1,211,284 shares, compared to its average volume of 332,815. The company has a market cap of $3.83 billion, a price-to-earnings ratio of 33.89, a PEG ratio of 1.72 and a beta of 1.24. Integer has a twelve month low of $107.11 and a twelve month high of $146.36. The business's fifty day moving average is $128.00 and its two-hundred day moving average is $131.73. The company has a debt-to-equity ratio of 0.62, a current ratio of 2.95 and a quick ratio of 2.09.

Integer (NYSE:ITGR - Get Free Report) last posted its quarterly earnings results on Thursday, February 20th. The medical equipment provider reported $1.43 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.46 by ($0.03). Integer had a return on equity of 11.65% and a net margin of 6.92%. The business had revenue of $449.50 million during the quarter, compared to analyst estimates of $446.28 million. As a group, research analysts expect that Integer will post 6.01 EPS for the current year.

Remove Ads

Hedge Funds Weigh In On Integer

Several institutional investors have recently added to or reduced their stakes in ITGR. Mather Group LLC. boosted its position in Integer by 304.3% in the 4th quarter. Mather Group LLC. now owns 190 shares of the medical equipment provider's stock valued at $25,000 after buying an additional 143 shares during the last quarter. Lee Danner & Bass Inc. acquired a new stake in Integer in the fourth quarter worth about $27,000. R Squared Ltd bought a new stake in Integer during the 4th quarter worth about $44,000. Sterling Capital Management LLC boosted its stake in shares of Integer by 472.9% in the 4th quarter. Sterling Capital Management LLC now owns 338 shares of the medical equipment provider's stock valued at $45,000 after purchasing an additional 279 shares during the last quarter. Finally, Versant Capital Management Inc grew its position in shares of Integer by 98.4% during the 4th quarter. Versant Capital Management Inc now owns 369 shares of the medical equipment provider's stock worth $49,000 after buying an additional 183 shares during the period. 99.29% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on ITGR shares. Oppenheimer lowered Integer from an "outperform" rating to a "market perform" rating in a research report on Friday, February 21st. Citigroup raised their price objective on shares of Integer from $130.00 to $145.00 and gave the company a "neutral" rating in a research report on Wednesday, December 11th. KeyCorp boosted their target price on shares of Integer from $144.00 to $154.00 and gave the stock an "overweight" rating in a research report on Friday, January 24th. Truist Financial raised their price target on shares of Integer from $147.00 to $163.00 and gave the company a "buy" rating in a report on Wednesday, December 11th. Finally, Benchmark upped their price objective on shares of Integer from $140.00 to $150.00 and gave the stock a "buy" rating in a report on Friday, February 21st. Two research analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $148.56.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.